Your Amazon Alexa may one day imitate the voices of your deceased loved ones, which is about as morbid as it is interesting. Cue the intro to “Black Mirror”.
In healthcare news, Juul is in trouble after the FDA finally acted on the company’s marketing request.
Welcome to night health care, where we follow the latest developments in policies and news concerning your health. For The Hill, we are Peter Sullivan, Nathaniel Weixel and Joseph Choi. Did someone forward this newsletter to you? Subscribe here.
FDA bans sale of Juul e-cigarettes
The Food and Drug Administration (FDA) said Thursday it was banning the sale of Juul e-cigarettes, a blow to the company that was responsible for the youth vaping epidemic.
- The agency said Juul had not demonstrated that keeping its products on the market “would be appropriate for the protection of public health.”
- Consumers who have previously purchased and are currently using Juul pods will not be restricted, the FDA said.
The move is part of a broader FDA review of the vaping industry as the agency decides which products to allow on the market. The FDA has cleared some e-cigarette applications over the past year, but these are not the products with major market share.
Security concerns: The FDA action was not related to youth vaping.
The agency said the marketing denial was due to the company providing “insufficient and conflicting data” on potentially harmful chemicals leaking from its e-liquid pods.
But hard to forget: FDA Commissioner Robert Califf in a statement said Juul “has played a disproportionate role in increasing youth vaping.”
“Today’s action is further progress on the FDA’s commitment to ensure that all e-cigarette and e-nicotine delivery system products currently marketed to consumers meet our public health standards.” , Califf said.
Juul is no more among the biggest brands children’s favorite because it no longer sells fruit flavored cartridges. According to the government’s annual National Youth Smoking Survey, less than 6% of young people currently of secondary school age said they prefer Juul.
Panel OKs Moderna two-dose vaccine for children 6-17 years old
A Centers for Disease Control and Prevention (CDC) advisory group on Thursday gave the green light to Moderna’s vaccine for children ages 6 to 17, bringing it closer to becoming the second vaccine in the United States eligible for use in children. .
The CDC’s Advisory Committee on Immunization Practices (ACIP) on Thursday unanimously approved Moderna’s vaccine for use in people ages 6 to 17.
CDC Director Rochelle Walensky is likely to sign off on the committee’s recommendation, as the agency almost always tracks ACIP approvals.
Currently, the only COVID-19 vaccine licensed for use in children between the ages of 6 and 17 is Pfizer’s two-dose mRNA vaccine.
- Walensky has already sign on the committee’s previous recommendation that coronavirus vaccines from Pfizer and Moderna should be given to children under the age of 5, with administration of these reduced doses having already begun.
- While a majority of American adults and older children would be fully vaccinated against COVID-19, a minority of eligible young children can currently say the same. The most recent data from the CDC shows that 29.5% of children between the ages of 5 and 11 are fully vaccinated.
HARRIS MEETS WITH DEMOCRATIC STATE AGS ON ABORTION RIGHTS
Vice President Harris met with Democratic attorneys general from seven states on Thursday about abortion rights as the White House prepares for a Supreme Court ruling reversing the landmark Roe v. Wade.
- Harris spoke with the attorneys general of Wisconsin, Nevada, Illinois, California, Delaware, New York and Washington state at the White House on Thursday afternoon about protecting of the right to abortion.
- “I asked these attorneys general to meet with us knowing that they have a central role to play in defending women’s reproductive freedom and their rights to make decisions about their own bodies,” Harris said in brief remarks to reporters at the start of the meeting at the Vice President’s ceremonial office.
Harris, who has been a leading voice in the White House on the abortion issue, and other officials convened a series of meetings with abortion rights advocates, groups, representatives of the state and other stakeholders over the past several weeks in preparation for the Supreme Court’s decision. , which will come anytime by the end of June.
NYC MAKES VAX OPEN TO PEOPLE POSSIBLY EXPOSED TO MONKEYPOX
The New York City Department of Health and Mental Hygiene abruptly announced on Thursday that it would offer vaccines to New Yorkers who may have been exposed to monkeypox.
In a statement, the department said adult men who have sex with men and have had sex with multiple or anonymous partners in the past 14 days will be eligible to receive smallpox vaccines that would be also effective against monkeypox.
- The vaccine available to New Yorkers is the Jynneos smallpox vaccine, given in two doses four weeks apart.
- The doses will be administered at the Chelsea Sexual Health Clinic, which will be open Sunday through Thursday from 11 a.m. to 7 p.m.
According to the most recent data from the Centers for Disease Control and Prevention (CDC), more than 150 cases of monkeypox have been confirmed in 24 US states and territories. New York has confirmed 22 cases so far.
Limited walk-in visits to receive vaccines will be accepted, but appointments – which can be made here — are preferred. From Thursday afternoon, no appointments are available.
Birx: Downplaying COVID has led to a ‘false sense of security’
Deborah Birxthe former White House coronavirus response coordinator, told a House committee on Thursday that the Trump administration failed to communicate the severity of COVID-19 early in the pandemic, which has led to inaction and a false sense of security across government.
- Testifying before the House Special Subcommittee on the Coronavirus Crisis, Birx said a clear and concise message about the seriousness of the COVID-19 virus was needed early in the pandemic, noting that data from China and from Europe had already indicated the risks of the pathogen even before it reached the United States
- The “continual communication to underestimate the seriousness of this pandemic” ultimately resulted in “inaction early on, I think, in our agencies, but also created a false sense of security in America,” Birx said.
“You cannot contain a virus that cannot be seen. And it wasn’t seen because we weren’t testing,” she said.
Weak start: Birx said the White House was already behind in its efforts to respond to the coronavirus pandemic in several ways early on, such as believing the virus could be tracked through symptomatic cases while the risk of viral spread asymptomatic was already known from other pathogens.
“I think from the start the CDC believed this could only be tracked by symptoms and did not prepare for asymptomatic community spread or develop the data and infrastructure to track this,” Birx said.
WHAT WE READ
- Wearables collect a flood of data. An ambitious new pregnancy study aims to prove it’s valuable for your health (Statistical)
- Fauci says he is ‘the example’ for COVID-19 vaccinations (Associated Press)
- They searched online for abortion clinics. They found anti-abortion centers (New York Times)
- The US response to monkeypox mirrors the early missteps of the coronavirus, experts say (The Washington Post)
STATE BY STATE
- Trump’s legacy looms large as Colorado aims to close the Hispanic insurance gap (Kaiser Health News)
- The House speaker adds another Medicaid expansion plan to the mix (North Carolina Health News)
- Protect yourself: Virus found in Michigan mosquitoes (The Detroit News)
THE OP-EDS HILL
That’s all for today, thanks for reading. Discover The Hill’s Healthcare page for the latest news and coverage. Until tomorrow.